Autoinflammatory diseases such as Still’s disease, Behçet’s disease, and most cases of HA20 are well treated with IL-1 blockade, which has only marginal effect in autoimmune diseases including RA (136). The gene discussed is IL1B; the disease is systemic-onset juvenile idiopathic arthritis.